Launch of new customer-focused website
Fusion Antibodies plc has launched a new customer-focused website to enhance the presentation of its antibody discovery, engineering, and supply capabilities, including its proprietary technologies and library-based discovery platforms, aiming to simplify how existing and prospective clients understand its services.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces the launch of its new customer-focused website.
The redesigned website provides an updated presentation of Fusion’s antibody discovery, engineering and supply capabilities and is intended to make it easier for existing and prospective customers to understand the Company’s range of services and proprietary technologies, including its library-based discovery platforms.
The website remains available at www.fusionantibodies.com.
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.